These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16054098)
1. Insulin acutely decreases hepatic fatty acid synthase activity. Najjar SM; Yang Y; Fernström MA; Lee SJ; Deangelis AM; Rjaily GA; Al-Share QY; Dai T; Miller TA; Ratnam S; Ruch RJ; Smith S; Lin SH; Beauchemin N; Oyarce AM Cell Metab; 2005 Jul; 2(1):43-53. PubMed ID: 16054098 [TBL] [Abstract][Full Text] [Related]
2. Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice. Russo L; Muturi HT; Ghadieh HE; Ghanem SS; Bowman TA; Noh HL; Dagdeviren S; Dogbey GY; Kim JK; Heinrich G; Najjar SM Diabetologia; 2017 Dec; 60(12):2463-2474. PubMed ID: 28913658 [TBL] [Abstract][Full Text] [Related]
3. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition. Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. Park SY; Cho YR; Kim HJ; Hong EG; Higashimori T; Lee SJ; Goldberg IJ; Shulman GI; Najjar SM; Kim JK Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E517-24. PubMed ID: 16638824 [TBL] [Abstract][Full Text] [Related]
5. Loss of CEACAM1 in hepatocytes causes hepatic fibrosis. Zaidi S; Asalla S; Muturi HT; Russo L; Abdolahipour R; Belew GD; Iglesias MB; Feraudo M; Leon L; Kuo E; Liu X; Kumarasamy S; Ghadieh HE; Gatto-Weis C; Zarrinpar A; Duarte S; Najjar SM Eur J Clin Invest; 2024 Jul; 54(7):e14177. PubMed ID: 38381498 [TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism. DeAngelis AM; Heinrich G; Dai T; Bowman TA; Patel PR; Lee SJ; Hong EG; Jung DY; Assmann A; Kulkarni RN; Kim JK; Najjar SM Diabetes; 2008 Sep; 57(9):2296-303. PubMed ID: 18544705 [TBL] [Abstract][Full Text] [Related]
7. CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation. Abou-Rjaily GA; Lee SJ; May D; Al-Share QY; Deangelis AM; Ruch RJ; Neumaier M; Kalthoff H; Lin SH; Najjar SM J Clin Invest; 2004 Oct; 114(7):944-52. PubMed ID: 15467833 [TBL] [Abstract][Full Text] [Related]
8. Holding the line on hepatic fat. Saltiel AR Cell Metab; 2005 Jul; 2(1):1-2. PubMed ID: 16054091 [TBL] [Abstract][Full Text] [Related]
9. Ceacam1 deletion causes vascular alterations in large vessels. Najjar SM; Ledford KJ; Abdallah SL; Paus A; Russo L; Kaw MK; Ramakrishnan SK; Muturi HT; Raphael CK; Lester SG; Heinrich G; Pierre SV; Benndorf R; Kleff V; Jaffa AA; Lévy E; Vazquez G; Goldberg IJ; Beauchemin N; Scalia R; Ergün S Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E519-29. PubMed ID: 23800882 [TBL] [Abstract][Full Text] [Related]
10. CEACAM1 regulates insulin clearance in liver. Poy MN; Yang Y; Rezaei K; Fernström MA; Lee AD; Kido Y; Erickson SK; Najjar SM Nat Genet; 2002 Mar; 30(3):270-6. PubMed ID: 11850617 [TBL] [Abstract][Full Text] [Related]
11. Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. Al-Share QY; DeAngelis AM; Lester SG; Bowman TA; Ramakrishnan SK; Abdallah SL; Russo L; Patel PR; Kaw MK; Raphael CK; Kim AJ; Heinrich G; Lee AD; Kim JK; Kulkarni RN; Philbrick WM; Najjar SM Diabetes; 2015 Aug; 64(8):2780-90. PubMed ID: 25972571 [TBL] [Abstract][Full Text] [Related]
12. Regulation of insulin action by CEACAM1. Najjar SM Trends Endocrinol Metab; 2002 Aug; 13(6):240-5. PubMed ID: 12128284 [TBL] [Abstract][Full Text] [Related]
13. Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. Dai T; Abou-Rjaily GA; Al-Share' QY; Yang Y; Fernström MA; Deangelis AM; Lee AD; Sweetman L; Amato A; Pasquali M; Lopaschuk GD; Erickson SK; Najjar SM J Biol Chem; 2004 Oct; 279(43):45155-61. PubMed ID: 15316023 [TBL] [Abstract][Full Text] [Related]
14. Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene. Russo L; Muturi HT; Ghadieh HE; Wisniewski AM; Morgan EE; Quadri SS; Landesberg GP; Siragy HM; Vazquez G; Scalia R; Gupta R; Najjar SM Mol Metab; 2018 Mar; 9():98-113. PubMed ID: 29396368 [TBL] [Abstract][Full Text] [Related]
15. Exercise attenuates nuclear protein binding to gene regulatory sequences of hepatic fatty acid synthase. Fiebig R; Gore MT; Ji LL J Appl Physiol (1985); 1999 Sep; 87(3):1009-15. PubMed ID: 10484571 [TBL] [Abstract][Full Text] [Related]
16. Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis. Ghadieh HE; Russo L; Muturi HT; Ghanem SS; Manaserh IH; Noh HL; Suk S; Kim JK; Hill JW; Najjar SM Metabolism; 2019 Apr; 93():33-43. PubMed ID: 30664851 [TBL] [Abstract][Full Text] [Related]